PLoS One.

Seeger H, Lindenmeyer MT, Cohen CD, Jaeckel C, Nelson PJ, Chen J, Edenhofer I, Kozakowski N, Regele H, Boehmig G, Brandt S, Wuethrich RP, Heikenwalder M, Fehr T, Segerer S. Lymphotoxin expression in human and murine renal allografts. PLoS One. 2018 Jan 4;13(1):e0189396. doi: 10.1371/journal.pone.0189396. PMID: 29300739; PMCID: PMC5754061.

Lindenmeyer, 2018

Metabolic pathways and immunometabolism in rare kidney diseases.

Grayson PC, Eddy S, Taroni JN, Lightfoot YL, Mariani L, Parikh H, Lindenmeyer MT, Ju W, Greene CS, Godfrey B, Cohen CD, Krischer J, Kretzler M, Merkel PA; Vasculitis Clinical Research Consortium, the European Renal cDNA Bank cohort, and the Nephrotic Syndrome Study Network. Metabolic pathways and immunometabolism in rare kidney diseases. Ann Rheum Dis. 2018 Aug;77(8):1226-1233. doi: 10.1136/annrheumdis-2017-212935. Epub 2018 May 3. PMID: 29724730; PMCID: PMC6045442.

Lindenmeyer, 2018

J Pathol.

Papakrivopoulou E, Vasilopoulou E, Lindenmeyer MT, Pacheco S, Brzóska HŁ, Price KL, Kolatsi-Joannou M, White KE, Henderson DJ, Dean CH, Cohen CD, Salama AD, Woolf AS, Long DA. Vangl2, a planar cell polarity molecule, is implicated in irreversible and reversible kidney glomerular injury. J Pathol. 2018 Dec;246(4):485-496. doi: 10.1002/path.5158. PMID: 30125361; PMCID: PMC6282744.

Lindenmeyer, 2018

Martinistraße 52
Campus Research II N25
20246 Hamburg Germany
This email address is being protected from spambots. You need JavaScript enabled to view it.

University Medical Center Hamburg - Eppendorf